pharma · Minimal Residual Disease · Pancreatic Ductal Adenocarcinoma · ELTX
Elicio Therapeutics
Elicio Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Boston, USA HQ
47 Employees
Public company Type
ELTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 47
- Programs
- 2
- Drugs
- 0
- Patents
- 4
Elicio Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Elicio Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.